Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Callahan

Showing results (291-300 of 336) with videos related to

Pageof 34
Sort By:
Obesity Pillars|June 8, 2026
Corrigendum to "Nutritional priorities to support GLP-1 therapy for obesity: A joint advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and The Obesity Society [Obesity Pillars 15 (2025) 100181]Dariush Mozaffarian, Monica Agarwal, Monica Aggarwal, et al.
The American Journal of Clinical Nutrition|April 10, 2026
Corrigendum to Nutritional priorities to support GLP-1 therapy for obesity: a joint Advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and The Obesity Society [Am J Clin Nutr 2025; 122: 344-367]Dariush Mozaffarian, Monica Agarwal, Monica Aggarwal, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 12, 2011
Targeting superficial or nodular Basal cell carcinoma with topically formulated small molecule inhibitor of smoothenedTracy Tang, Jean Y Tang, Dongwei Li, et al.
JAMA Oncology|March 10, 2018
Pacritinib vs Best Available Therapy, Including Ruxolitinib, in Patients With Myelofibrosis: A Randomized Clinical TrialJohn Mascarenhas, Ronald Hoffman, Moshe Talpaz, et al.
Journal of Translational Medicine|November 30, 2011
Antibodies against insulin measured by electrochemiluminescence predicts insulitis severity and disease onset in non-obese diabetic mice and can distinguish human type 1 diabetes statusBernice Lo, Austin D E Swafford, Kimberly A Shafer-Weaver, et al.
Physical Review Letters|March 4, 2014
Design of a high-foot high-adiabat ICF capsule for the national ignition facilityT R Dittrich, O A Hurricane, D A Callahan, et al.
Physical Review Letters|March 4, 2014
High-adiabat high-foot inertial confinement fusion implosion experiments on the national ignition facilityH-S Park, O A Hurricane, D A Callahan, et al.
Science (New York, N.Y.)|September 4, 2009
Smoothened mutation confers resistance to a Hedgehog pathway inhibitor in medulloblastomaRobert L Yauch, Gerrit J P Dijkgraaf, Bruno Alicke, et al.
Environmental Research|April 12, 2005
Indoor exposures to air pollutants and allergens in the homes of asthmatic children in inner-city BaltimorePatrick N Breysse, Timothy J Buckley, D'Ann Williams, et al.
The Review of Scientific Instruments|November 7, 2012
South pole bang-time diagnostic on the National Ignition Facility (invited)D H Edgell, D K Bradley, E J Bond, et al.
Pageof 34

Showing results (291-300 of 336) with videos related to

Sort By:
Pageof 34
Obesity Pillars|June 8, 2026
Corrigendum to "Nutritional priorities to support GLP-1 therapy for obesity: A joint advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and The Obesity Society [Obesity Pillars 15 (2025) 100181]Dariush Mozaffarian, Monica Agarwal, Monica Aggarwal, et al.
The American Journal of Clinical Nutrition|April 10, 2026
Corrigendum to Nutritional priorities to support GLP-1 therapy for obesity: a joint Advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and The Obesity Society [Am J Clin Nutr 2025; 122: 344-367]Dariush Mozaffarian, Monica Agarwal, Monica Aggarwal, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 12, 2011
Targeting superficial or nodular Basal cell carcinoma with topically formulated small molecule inhibitor of smoothenedTracy Tang, Jean Y Tang, Dongwei Li, et al.
JAMA Oncology|March 10, 2018
Pacritinib vs Best Available Therapy, Including Ruxolitinib, in Patients With Myelofibrosis: A Randomized Clinical TrialJohn Mascarenhas, Ronald Hoffman, Moshe Talpaz, et al.
Journal of Translational Medicine|November 30, 2011
Antibodies against insulin measured by electrochemiluminescence predicts insulitis severity and disease onset in non-obese diabetic mice and can distinguish human type 1 diabetes statusBernice Lo, Austin D E Swafford, Kimberly A Shafer-Weaver, et al.
Physical Review Letters|March 4, 2014
Design of a high-foot high-adiabat ICF capsule for the national ignition facilityT R Dittrich, O A Hurricane, D A Callahan, et al.
Physical Review Letters|March 4, 2014
High-adiabat high-foot inertial confinement fusion implosion experiments on the national ignition facilityH-S Park, O A Hurricane, D A Callahan, et al.
Science (New York, N.Y.)|September 4, 2009
Smoothened mutation confers resistance to a Hedgehog pathway inhibitor in medulloblastomaRobert L Yauch, Gerrit J P Dijkgraaf, Bruno Alicke, et al.
Environmental Research|April 12, 2005
Indoor exposures to air pollutants and allergens in the homes of asthmatic children in inner-city BaltimorePatrick N Breysse, Timothy J Buckley, D'Ann Williams, et al.
The Review of Scientific Instruments|November 7, 2012
South pole bang-time diagnostic on the National Ignition Facility (invited)D H Edgell, D K Bradley, E J Bond, et al.
Pageof 34